Tirbanibulin for actinic keratosis on the face
Part of Cancer, Skin clinical trials.
This study tests a cream called tirbanibulin (Klisyri) for adults with 4 to 12 actinic keratosis (AK) spots on their face. It aims to see how well the treatment works when applied to a larger area of the face in everyday medical practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have actinic keratosis (AK) spots on your face
- You have between 4 and 12 AK spots that are clearly visible
- You are 18 years old or older
- You are willing to use sunscreen and avoid too much sun or UV light during the study
- You can read and write in English and agree to follow the study procedures
- You do not have other skin conditions or wounds on your face that could affect the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether tirbanibulin (Klisyri) cream works well on specific types of actinic keratosis on the scalp or face that have a downward growth pattern. It helps doctors understand if this treatment is right for those skin spots.
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
This study tests a new sunscreen (Anthelos Fluide 100 KA+ UVMune 400) to see if it can protect skin and prevent further sun damage in people who already have multiple actinic keratoses (precancerous spots). It may help reduce the risk of new spots or skin cancer.
This trial tests a two-step treatment for actinic keratosis (rough, scaly patches from sun damage) on the scalp and forehead. First, the patches are frozen (cryotherapy), then a medicated ointment (tirbanibulin) is applied. The goal is to see if this combination is safe and works better than freezing alone.
This trial tests a reformulated light-activated cream (Levulan Kerastick) for treating actinic keratosis (precancerous skin spots) on the face or bald scalp. It is a phase 3 study to see if the new version works better with fewer side effects.
Hear when a new Actinic Keratosis (AK) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.